Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
The biopharma world's manufacturing weekly
Manufacturing channel feed
Australia's BioCina and NovaCina join forces to make one CDMO
4 months ago
Deals
Aragen gets $100M from private equity firm to expand manufacturing footprint
4 months ago
Financing
AstraZeneca, CRISPR tools supplier ink gene editing enzyme licensing deal
4 months ago
Deals
Samsung Bio extends ADC partnership; Veeda rebrands as CDMO
4 months ago
Synaffix adds Boehringer and Mitsubishi Tanabe as ADC licensing partners
4 months ago
Deals
Resilience cuts 120 employees at a former bluebird gene therapy site
4 months ago
People
BWX Technologies to buy Canadian isotope maker for $525M
4 months ago
Deals
Pharma
Anthem Biosciences eyes $397M public offering in India
4 months ago
Financing
WuXi Biologics to sell Irish vaccine site to Merck for $500M
4 months ago
China
WuXi AppTec will sell cell and gene therapy business to private equity firm
5 months ago
China
Cell/Gene Tx
Lonza expands capsule footprint; BioCentriq's new HQ
5 months ago
Post-Hoc: Biosecure is dead. Long live Biosecure?
5 months ago
Editor's note
China
FDA rejects J&J’s subcutaneous Rybrevant over manufacturing issues
5 months ago
Pharma
Novo Nordisk to spend $1.2B for new rare disease drug factory in Denmark
5 months ago
FTC OKs Novo-Catalent deal in major win for Novo Nordisk’s GLP-1 manufacturing
5 months ago
Deals
Daiichi's $150M build in China; BioMarin reveals €60M Irish expansion
5 months ago
Lonza looks to depart capsule and health ingredients as it undergoes restructure
5 months ago
People
Biosecure bill is left out of end-of-year defense package, dealing blow to chances
5 months ago
China
FDA+
European Commission greenlights $16.5B Novo-Catalent acquisition
5 months ago
Deals
FDA+
National Resilience to cut 105 employees at Florida site as new CEO takes over
5 months ago
People
UK’s local vaccine production stymied by budget cuts, government committee says
5 months ago
Lilly continues to expand its empire of GLP-1 factories with new $3B buildout
5 months ago
Pharma
Biosecure compromise could add executive review process for named companies, sources say
5 months ago
R&D
FDA+
Amgen deepens roots in North Carolina with latest $1B factory build
5 months ago
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page
